Publikationen von 0000-0002-9693-3221
(ORCID: 0000-0002-9693-3221)
 | Eine Stufe nach oben |
Anzahl der Einträge: 2.
2023
Meyer, Stefanie, Buser, Lorenz 
, Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus
(2023)
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma.
European Journal of Cancer 182, S. 77-86.
Volltext nicht vorhanden.
, Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus
(2023)
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma.
European Journal of Cancer 182, S. 77-86.
Volltext nicht vorhanden.
2019
Hutterer, Georg C., Posch, Florian, Buser, Lorenz , Zigeuner, Richard, Morshäuser, Laura, Otto, Wolfgang, Wild, Peter J., Burger, Maximilian, May, Matthias, Pichler, Martin und Brookman-May, Sabine D.
(2019)
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urologic Oncology: Seminars and Original Investigations 37 (7), S. 510-518.
Volltext nicht vorhanden.
, Zigeuner, Richard, Morshäuser, Laura, Otto, Wolfgang, Wild, Peter J., Burger, Maximilian, May, Matthias, Pichler, Martin und Brookman-May, Sabine D.
(2019)
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urologic Oncology: Seminars and Original Investigations 37 (7), S. 510-518.
Volltext nicht vorhanden.